Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular immunity in recurrent vulvovaginal candidiasis

E M Corrigan1, R L Clancy, M L Dunkley

  • 1Australian Institute of Mucosal Immunology, Newcastle, NSW.

Clinical and Experimental Immunology
|April 7, 1998
PubMed
Summary

Women with recurrent vaginal candidiasis show impaired T cell function, particularly during the follicular phase. This cellular immune dysregulation may increase susceptibility to yeast infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-site placebo-controlled randomised clinical trial to assess protection following oral immunisation with inactivated non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.

Internal medicine journal·2016
Same author

Induction of partial immunity in both males and females is sufficient to protect females against sexual transmission of Chlamydia.

Mucosal immunology·2015
Same author

Chlamydia pneumoniae and Chlamydia Trachomatis Infection Differentially Modulates Human Dendritic Cell Line (MUTZ) Differentiation and Activation.

Scandinavian journal of immunology·2015
Same author

The mouse model of Chlamydia genital tract infection: a review of infection, disease, immunity and vaccine development.

Current molecular medicine·2013
Same author

Ovarian steroid hormones: effects on immune responses and Chlamydia trachomatis infections of the female genital tract.

Mucosal immunology·2013
Same author

The effect of immunosuppressive agents on monocyte generation and cytokine expression.

Inflammatory bowel diseases·2013

Area of Science:

  • Immunology
  • Gynecology
  • Microbiology

Background:

  • Recurrent vulvovaginal candidiasis (RVVC) is linked to impaired T cell function, though findings vary.
  • Clinical episodes often occur in the luteal phase, suggesting hormonal effects on immunity.

Purpose of the Study:

  • To assess cellular immune responses in women with RVVC.
  • To investigate the influence of the menstrual cycle phase (follicular vs. luteal) on immune responses to Candida.

Main Methods:

  • Compared peripheral blood lymphocyte proliferation and cytokine production (Interferon-gamma) in 28 RVVC patients and 25 controls.
  • Assessed responses to Candida and purified protein derivative (PPD) stimulation.
  • Correlated immune responses with menstrual cycle phase.

Related Experiment Videos

Main Results:

  • Patients with RVVC had significantly reduced Candida-stimulated lymphocyte proliferation and Interferon-gamma (IFN-gamma) production compared to controls.
  • Lower Candida-stimulated IFN-gamma production was observed in RVVC patients during the follicular phase versus the luteal phase.
  • A trend towards reduced Candida-stimulated proliferation was noted in follicular phase patients.

Conclusions:

  • RVVC is associated with partial T cell dysregulation.
  • Hormonal changes during the follicular phase may exacerbate this immune dysfunction, increasing infection risk.